Key Details
Price
$241.40Last Dividend
$0.53Annual ROE
22.70%Beta
0.88Events Calendar
Next earnings date:
Apr 25, 2025Recent quarterly earnings:
Jan 30, 2025Recent annual earnings:
Aug 01, 2024Next ex-dividend date:
Feb 13, 2025Recent ex-dividend date:
Nov 07, 2024Next split:
N/ARecent split:
Aug 31, 2010Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
On January 30, ResMed (RMD 1.89%), a top company in sleep apnea and respiratory care, announced impressive earnings for the second quarter of fiscal 2025. The medical device firm exceeded analysts' predictions with an adjusted earnings per share (EPS) of $2.43, surpassing the $2.32 estimate, and reported revenue of $1.282 billion, which was higher than the expected $1.266 billion.
While the revenue and earnings per share (EPS) for ResMed (RMD) provide insight into its performance for the quarter ending December 2024, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.
ResMed (RMD) reported quarterly earnings of $2.43 per share, which is higher than the Zacks Consensus Estimate of $2.30 per share. This is an increase compared to earnings of $1.88 per share from the same period last year.
On Thursday, ResMed exceeded Wall Street's profit expectations for the second quarter, thanks to high demand for its devices that help treat sleep apnea, a widespread sleep issue.
Please be aware that a webcast of ResMed's conference call can be accessed today at 4:30 p.m. ET by visiting http://investor.resmed.com.
ResMed (RMD) lacks the necessary elements that could lead to a strong earnings report in the near future. Be ready for the important expectations.
This week's article features Chipotle Mexican Grill, ResMed, and ServiceNow. They have been spotlighted in the Screen of The Week.
Our Zacks Earnings ESP makes it simpler to identify stocks that are likely to exceed quarterly earnings predictions.
Chipotle Mexican Grill, Ulta Beauty, and ServiceNow are showing impressive growth in their earnings right now.
ResMed (RMD) is likely to do better than the market because it shows strong growth in its financial performance.
FAQ
- What is the primary business of ResMed?
- What is the ticker symbol for ResMed?
- Does ResMed pay dividends?
- What sector is ResMed in?
- What industry is ResMed in?
- What country is ResMed based in?
- When did ResMed go public?
- Is ResMed in the S&P 500?
- Is ResMed in the NASDAQ 100?
- Is ResMed in the Dow Jones?
- When was ResMed's last earnings report?
- When does ResMed report earnings?
- Should I buy ResMed stock now?